Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Apexbio Technology LLC PPT 263717-53-9 10mg
SDP

Catalog No. 5000090847
Encompass_Preferred

PPT (263717-53-9) is a small-molecule agonist targeting estrogen receptor (ER ) It is designed to selectively activate ER thereby modulating estrogen-mediated signaling pathways PPT exerts its biological activity primarily through receptor subtype-specific agonism displaying a relative binding affinity for ER (49%) that is 410-fold higher than for estrogen receptor (ER 0 12%) Based on these pharmacological properties PPT holds research potential in studying ER -mediated cellular responses gene expression changes and investigating estrogen-related mechanisms including receptor-specific cell proliferation differentiation and physiological processes regulated through the ER signaling axis

Catalog No. 50-000-90847 Supplier Apexbio Technology LLC Supplier No. B673510
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

PPT (263717-53-9) is a small-molecule agonist targeting estrogen receptor (ER ) It is designed to selectively activate ER thereby modulating estrogen-mediated signaling pathways PPT exerts its biological activity primarily through receptor subtype-specific agonism displaying a relative binding affinity for ER (49%) that is 410-fold higher than for estrogen receptor (ER 0 12%) Based on these pharmacological properties PPT holds research potential in studying ER -mediated cellular responses gene expression changes and investigating estrogen-related mechanisms including receptor-specific cell proliferation differentiation and physiological processes regulated through the ER signaling axis

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.